tradingkey.logo

Amneal Pharmaceuticals Inc

AMRX
14.520USD
-0.250-1.69%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
4.56BValor de mercado
814.81P/L TTM

Amneal Pharmaceuticals Inc

14.520
-0.250-1.69%

Mais detalhes de Amneal Pharmaceuticals Inc Empresa

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Informações de Amneal Pharmaceuticals Inc

Código da empresaAMRX
Nome da EmpresaAmneal Pharmaceuticals Inc
Data de listagemNov 18, 2009
CEOPatel (Chintu)
Número de funcionários8100
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 18
Endereço400 Crossing Boulevard, 3rd Floor
CidadeBRIDGEWATER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal08807
Telefone19089473120
Sitehttps://amneal.com/
Código da empresaAMRX
Data de listagemNov 18, 2009
CEOPatel (Chintu)

Executivos da empresa Amneal Pharmaceuticals Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
25.62M
--
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.61M
-151332.00%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
621.88K
+151496.00%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
285.99K
+40258.00%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
191.40K
--
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
+40258.00%
Buchi (J Kevin)
Buchi (J Kevin)
Independent Director
Independent Director
--
--
Mr. Andrew S. Boyer
Mr. Andrew S. Boyer
Executive Vice President, Chief Commercial Officer - Generics
Executive Vice President, Chief Commercial Officer - Generics
--
--
Mr. Chirag Patel
Mr. Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
President, Co-Chief Executive Officer, Co-Founder, Director
--
--
Mr. Ted Nark
Mr. Ted Nark
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
25.62M
--
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.61M
-151332.00%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
621.88K
+151496.00%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
285.99K
+40258.00%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
191.40K
--
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
+40258.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Oral solid
180.46M
23.00%
Distribution
96.22M
12.26%
Government label
87.75M
11.19%
Auto-injector
78.94M
10.06%
Central Nervous System
77.63M
9.90%
Outro
263.51M
33.59%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Oral solid
180.46M
23.00%
Distribution
96.22M
12.26%
Government label
87.75M
11.19%
Auto-injector
78.94M
10.06%
Central Nervous System
77.63M
9.90%
Outro
263.51M
33.59%

Distribuição de ações

Atualizado em: dom, 11 de jan
Atualizado em: dom, 11 de jan
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Patel (Tushar Bhikhubhai)
15.45%
Patel (Chintu)
8.15%
Patel (Dipan)
7.58%
Patel (Chirag K)
7.04%
Akram (Mahesh)
6.54%
Outro
55.24%
Investidores
Investidores
Proporção
Patel (Tushar Bhikhubhai)
15.45%
Patel (Chintu)
8.15%
Patel (Dipan)
7.58%
Patel (Chirag K)
7.04%
Akram (Mahesh)
6.54%
Outro
55.24%
Tipos de investidores
Investidores
Proporção
Individual Investor
46.38%
Investment Advisor
19.73%
Investment Advisor/Hedge Fund
12.11%
Hedge Fund
11.57%
Private Equity
3.92%
Research Firm
1.93%
Pension Fund
0.28%
Bank and Trust
0.18%
Family Office
0.03%
Outro
3.87%

Participação acionária institucional

Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
448
154.72M
55.65%
+68.38K
2025Q3
455
154.66M
56.61%
+8.55M
2025Q2
432
145.89M
53.25%
+6.99M
2025Q1
416
138.78M
50.16%
-18.42M
2024Q4
398
129.01M
49.64%
-14.17M
2024Q3
380
143.02M
47.07%
+6.97M
2024Q2
372
135.82M
34.71%
+37.56M
2024Q1
356
97.40M
32.81%
-3.83M
2023Q4
348
89.35M
29.61%
+7.08M
2023Q3
338
82.03M
56.21%
+4.32M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Patel (Tushar Bhikhubhai)
48.58M
15.45%
-5.00M
-9.33%
Mar 14, 2025
Patel (Chintu)
25.62M
8.15%
--
--
Oct 03, 2025
Patel (Dipan)
23.83M
7.58%
--
--
Oct 03, 2025
Patel (Chirag K)
22.13M
7.04%
--
--
Aug 06, 2025
Akram (Mahesh)
20.56M
6.54%
-6.30M
-23.45%
Mar 31, 2025
The Vanguard Group, Inc.
17.90M
5.69%
+403.58K
+2.31%
Sep 30, 2025
Rubric Capital Management LP
12.33M
3.92%
+624.61K
+5.33%
Sep 30, 2025
TPG Capital, L.P.
12.33M
3.92%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
11.34M
3.61%
+697.25K
+6.55%
Sep 30, 2025
Citadel Advisors LLC
5.73M
1.82%
+104.62K
+1.86%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Invesco Pharmaceuticals ETF
3.08%
State Street SPDR S&P Pharmaceuticals ETF
2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2%
Invesco Dorsey Wright Healthcare Momentum ETF
0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
0.83%
First Trust NASDAQ Pharmaceuticals ETF
0.78%
First Trust Small Cap Growth AlphaDEX Fund
0.72%
iShares U.S. Pharmaceuticals ETF
0.68%
ProShares Ultra Nasdaq Biotechnology
0.48%
WisdomTree US SmallCap Fund
0.36%
Ver Mais
Invesco Pharmaceuticals ETF
Proporção3.08%
State Street SPDR S&P Pharmaceuticals ETF
Proporção2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporção2%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
Proporção0.83%
First Trust NASDAQ Pharmaceuticals ETF
Proporção0.78%
First Trust Small Cap Growth AlphaDEX Fund
Proporção0.72%
iShares U.S. Pharmaceuticals ETF
Proporção0.68%
ProShares Ultra Nasdaq Biotechnology
Proporção0.48%
WisdomTree US SmallCap Fund
Proporção0.36%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI